Verition Fund Management
ABEO icon

Verition Fund Management’s Abeona Therapeutics ABEO Stock Holding History

Verition Fund Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,600
Closed -$755K – 1060
2020
Q3 		$755K Buy
+29,600
New +$1.87M 0.02% 447

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management's ABEO Position: Q4 2020 in Review

Verition Fund Management sold out of Abeona Therapeutics (ABEO) in Q4 2020, closing a stake of 29,600 shares — an estimated $755K sold.

Verition Fund Management first reported a position in ABEO in Q3 2020 and held it in 1 quarter. The position peaked at $755K in Q3 2020. 73 funds tracked by Wall St. Rank hold ABEO as of Q4 2020.

  • Verition Fund Management reported no remaining Abeona Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Verition Fund Management sold 29,600 Abeona Therapeutics shares in Q4 2020, an estimated $755K.
  • Verition Fund Management first reported a position in Abeona Therapeutics in Q3 2020 and held it in 1 quarter.
  • Verition Fund Management's Abeona Therapeutics position peaked at $755K in Q3 2020.
  • 73 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2020.

Based on Verition Fund Management's 13F filing for Q4 2020, filed 16 Feb 2021.